Measuring outcomes in economic evaluationsBMJ 1999; 319 doi: https://doi.org/10.1136/bmj.319.7211.705a (Published 11 September 1999) Cite this as: BMJ 1999;319:705
This economics note is misleading
- Simon Dixon, lecturer,
- Colin Green, research fellow
- Sheffield Health Economics Group, School of Health and Related Research, University of Sheffield, Sheffield S1 4DA
- University of York, York YO23 5DD
EDITOR—The series of occasional notes on economics has undoubtedly helped clinicians to understand the key concepts and jargon used by economists. The note discussing the use of outcome measures in economic evaluation is, however, misleading.1
Firstly, condition specific outcome measures and generic quality of life scales should not, in general, be used in cost effectiveness analysis.2 The primary reason for this is that such scales do not have the requisite interval properties. The scores produced by the short form-36 questionnaire (SF-36), for example, are little more than transformed ordinal rankings.
Even if interval properties can be shown, the use of generic quality of life scales in cost effectiveness analysis is severely restricted by their production of a set of scores reflecting different domains of health. For example, if the SF-36 is used in an evaluation, it can produce conflicting cost effectiveness ratios …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial